|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 109, Issue 1 67-73, Copyright © 1990 by Company of Biologists
JOURNAL ARTICLES |
PV Senior, S Byrne, WJ Brammar and F Beck
Department of Anatomy, University of Leicester, UK.
The insulin-like growth factor II (IGF-II) receptor is identical to the mannose-6-phosphate receptor (M-6-P), but its role as a somatomedin transducer is uncertain. IGF-II/M-6-P receptor expression was studied by in situ hybridization (ISH) in the developing rat. Expression occurs in extra-embryonic membranes at the time of IGF-II mRNA induction and later at paracrine/autocrine sites of IGF-II action (skeletal muscle and perichondrium) in the embryo. Highest levels of receptor mRNA occur in heart and major vessels. Postnatally transcription is strongly down-regulated. This suggests a role for the IGF-II/M-6-P receptor in IGF-II action or turnover during development distinct from its role in lysosomal transport.
This article has been cited by other articles:
|
|
 |
|
  A. Urayama, J. H. Grubb, W. S. Sly, and W. A. Banks Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier PNAS, August 24, 2004; 101(34): 12658 - 12663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Gicquel, J Weiss, J Amiel, V Gaston, Y Le Bouc, and C D Scott Epigenetic abnormalities of the mannose-6-phosphate/IGF2 receptor gene are uncommon in human overgrowth syndromes J. Med. Genet., January 1, 2004; 41(1): e4 - 4. [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Sands, C. A. Vogler, K. K. Ohlemiller, M. S. Roberts, J. H. Grubb, B. Levy, and W. S. Sly Biodistribution, Kinetics, and Efficacy of Highly Phosphorylated and Non-phosphorylated beta -Glucuronidase in the Murine Model of Mucopolysaccharidosis VII J. Biol. Chem., November 9, 2001; 276(46): 43160 - 43165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Burns and A. B. Hassan Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation Development, October 1, 2001; 128(19): 3819 - 3830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mendez, J. V. Planas, J. Castillo, I. Navarro, and J. Gutierrez Identification of a Type II Insulin-Like Growth Factor Receptor in Fish Embryos Endocrinology, March 1, 2001; 142(3): 1090 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Pandha, L.-A. Martin, A. Rigg, H. C. Hurst, G. W.H. Stamp, K. Sikora, and N. R. Lemoine Genetic Prodrug Activation Therapy for Breast Cancer: A Phase I Clinical Trial of erbB-2-Directed Suicide Gene Expression J. Clin. Oncol., July 1, 1999; 17(7): 2180 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Della, P. Senior, and D. Bowtell Isolation and characterisation of murine homologues of the Drosophila seven in absentia gene (sina) Development, January 4, 1993; 117(4): 1333 - 1343. [Abstract] [PDF]
|
|
|
|
 |
|
 D A Rappolee, K S Sturm, O Behrendtsen, G A Schultz, R A Pedersen, and Z Werb Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes & Dev., June 1, 1992; 6(6): 939 - 952. [Abstract] [PDF]
|
|
